Healthcare -
Biotechnology - NASDAQ - NL
$ 20.14
0.619 %
$ 2.26 B
Market Cap
-10.6
P/E
NAMS - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NAMS - NewAmsterdam Pharma Company N.V.
660 M
LAST VALUE
32.58%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR